HomeDOSE • CNSX
add
Rapid Dose Therapeutics Corp
Previous close
$0.20
Year range
$0.13 - $0.33
Market cap
25.91M CAD
Avg Volume
45.79K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Revenue | 668.58K | 247.04% |
Operating expense | 1.67M | 32.09% |
Net income | -1.68M | 18.12% |
Net profit margin | -251.55 | 76.41% |
Earnings per share | — | — |
EBITDA | -1.31M | -24.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.72K | -87.14% |
Total assets | 1.63M | -13.27% |
Total liabilities | 6.84M | 35.64% |
Total equity | -5.21M | — |
Shares outstanding | 129.53M | — |
Price to book | -4.88 | — |
Return on assets | -203.22% | — |
Return on capital | 164.24% | — |
Cash Flow
Net change in cash
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Net income | -1.68M | 18.12% |
Cash from operations | 4.64K | 100.36% |
Cash from investing | -5.74K | — |
Cash from financing | -18.28K | -101.42% |
Net change in cash | -19.38K | -278.48% |
Free cash flow | 400.97K | 125.53% |
About
Founded
2008
Headquarters
Website
